248 related articles for article (PubMed ID: 27238364)
1. Repositioning the Old Fungicide Ciclopirox for New Medical Uses.
Shen T; Huang S
Curr Pharm Des; 2016; 22(28):4443-50. PubMed ID: 27238364
[TBL] [Abstract][Full Text] [Related]
2. Reposition of the Fungicide Ciclopirox for Cancer Treatment.
Huang Z; Huang S
Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561
[TBL] [Abstract][Full Text] [Related]
3. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
Eberhard Y; McDermott SP; Wang X; Gronda M; Venugopal A; Wood TE; Hurren R; Datti A; Batey RA; Wrana J; Antholine WE; Dick JE; Schimmer AD
Blood; 2009 Oct; 114(14):3064-73. PubMed ID: 19589922
[TBL] [Abstract][Full Text] [Related]
4. The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis.
Linden T; Katschinski DM; Eckhardt K; Scheid A; Pagel H; Wenger RH
FASEB J; 2003 Apr; 17(6):761-3. PubMed ID: 12594177
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
Hoque M; Hanauske-Abel HM; Palumbo P; Saxena D; D'Alliessi Gandolfi D; Park MH; Pe'ery T; Mathews MB
Retrovirology; 2009 Oct; 6():90. PubMed ID: 19825182
[TBL] [Abstract][Full Text] [Related]
6. The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway.
Luo Y; Zhou H; Liu L; Shen T; Chen W; Xu B; Han X; Zhang F; Scott RS; Alexander JS; Alam A; Huang S
Oncogene; 2011 May; 30(18):2098-107. PubMed ID: 21217783
[TBL] [Abstract][Full Text] [Related]
7. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
8. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway.
Zhou H; Shen T; Shang C; Luo Y; Liu L; Yan J; Li Y; Huang S
Oncotarget; 2014 Oct; 5(20):10140-50. PubMed ID: 25294812
[TBL] [Abstract][Full Text] [Related]
9. The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.
Weir SJ; Patton L; Castle K; Rajewski L; Kasper J; Schimmer AD
J Clin Pharm Ther; 2011 Apr; 36(2):128-34. PubMed ID: 21366640
[TBL] [Abstract][Full Text] [Related]
10. Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines.
Wu J; Liu H; Zhang G; Gu L; Zhang Y; Gao J; Wei Y; Ma Z
PLoS One; 2016; 11(8):e0161509. PubMed ID: 27551974
[TBL] [Abstract][Full Text] [Related]
11. Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.
Mémin E; Hoque M; Jain MR; Heller DS; Li H; Cracchiolo B; Hanauske-Abel HM; Pe'ery T; Mathews MB
Cancer Res; 2014 Jan; 74(2):552-62. PubMed ID: 24220243
[TBL] [Abstract][Full Text] [Related]
12. Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.
Sen S; Hassane DC; Corbett C; Becker MW; Jordan CT; Guzman ML
Exp Hematol; 2013 Sep; 41(9):799-807.e4. PubMed ID: 23660068
[TBL] [Abstract][Full Text] [Related]
13. Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5'untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs.
Cáceres CJ; Angulo J; Contreras N; Pino K; Vera-Otarola J; López-Lastra M
Antiviral Res; 2016 Oct; 134():192-206. PubMed ID: 27633452
[TBL] [Abstract][Full Text] [Related]
14. The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro.
Clement PM; Hanauske-Abel HM; Wolff EC; Kleinman HK; Park MH
Int J Cancer; 2002 Aug; 100(4):491-8. PubMed ID: 12115536
[TBL] [Abstract][Full Text] [Related]
15. The antitumor activity of the fungicide ciclopirox.
Zhou H; Shen T; Luo Y; Liu L; Chen W; Xu B; Han X; Pang J; Rivera CA; Huang S
Int J Cancer; 2010 Nov; 127(10):2467-77. PubMed ID: 20225320
[TBL] [Abstract][Full Text] [Related]
16. Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes.
Mihailidou C; Chatzistamou I; Papavassiliou AG; Kiaris H
Pflugers Arch; 2016 Nov; 468(11-12):1957-1968. PubMed ID: 27757583
[TBL] [Abstract][Full Text] [Related]
17. Effects of hypoxia and intracellular iron chelation on hypoxia-inducible factor-1alpha and -1beta in the rat carotid body and glomus cells.
Baby SM; Roy A; Mokashi AM; Lahiri S
Histochem Cell Biol; 2003 Nov; 120(5):343-52. PubMed ID: 14600837
[TBL] [Abstract][Full Text] [Related]
18. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
[TBL] [Abstract][Full Text] [Related]
19. Ciclopirox Inhibition of eIF5A Hypusination Attenuates Fibroblast Activation and Cardiac Fibrosis.
Subbaiah KCV; Wu J; Tang WHW; Yao P
J Cardiovasc Dev Dis; 2023 Jan; 10(2):. PubMed ID: 36826549
[TBL] [Abstract][Full Text] [Related]
20. In vitro model of infected stratum corneum for the efficacy evaluation of poloxamer 407-based formulations of ciclopirox olamine against Trichophyton rubrum as well as differential scanning calorimetry and stability studies.
Täuber A; Müller-Goymann CC
Int J Pharm; 2015 Oct; 494(1):304-11. PubMed ID: 26276254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
